Albert Einstein College of Medicine
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1955-01-01
- Employees
- 1.9K
- Market Cap
- -
- Website
- http://einstein.yu.edu
Mitigating Sexual Stigma Within Healthcare Interactions Improve Engagement of MSM in HIV Prevention
Not Applicable
Completed
- Conditions
- Human Immunodeficiency VirusPatient EngagementStigma, Social
- Interventions
- Behavioral: A set of implementation strategies to reduce sexual stigma
- First Posted Date
- 2021-03-03
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Albert Einstein College of Medicine
- Target Recruit Count
- 113
- Registration Number
- NCT04779736
- Locations
- 🇺🇸
Albert Einstein College of Medicine, Bronx, New York, United States
Varenicline for Co-occurring Cannabis and Tobacco Use
Phase 4
Completed
- Conditions
- Tobacco DependenceCannabis Dependence
- Interventions
- Drug: Standard clinical care first, followed by standard clinical care and vareniclineDrug: Standard clinical care and varenicline first, followed by standard clinical care
- First Posted Date
- 2020-10-20
- Last Posted Date
- 2021-04-22
- Lead Sponsor
- Albert Einstein College of Medicine
- Target Recruit Count
- 7
- Registration Number
- NCT04595318
Carbon Ion RT for Locally Advanced Pancreatic Cancer
Phase 3
Terminated
- Conditions
- Pancreatic Cancer
- Interventions
- Radiation: carbon ion RTDrug: Chemotherapy drug
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- Albert Einstein College of Medicine
- Target Recruit Count
- 5
- Registration Number
- NCT04592861
- Locations
- 🇨🇳
Shanghai Proton and Heavy Ion Center (SPHIC), Shanghai, Shanghai, China
Percutaneous Interruption of the Coracohumeral Ligament for the Treatment of Frozen Shoulder
Not Applicable
Completed
- Conditions
- Adhesive Capsulitis
- Interventions
- Device: TenexDrug: Local anesthetic
- First Posted Date
- 2020-09-16
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- Albert Einstein College of Medicine
- Target Recruit Count
- 46
- Registration Number
- NCT04549051
- Locations
- 🇺🇸
Montefiore Medical Center, New York, New York, United States
Depression Treatment and Economic Empowerment
Not Applicable
Completed
- Conditions
- Depressive Symptoms
- Interventions
- Behavioral: Group based treatment
- First Posted Date
- 2020-08-31
- Last Posted Date
- 2020-08-31
- Lead Sponsor
- Albert Einstein College of Medicine
- Target Recruit Count
- 48
- Registration Number
- NCT04532008
FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy
Phase 1
Terminated
- Conditions
- Non Small Cell Lung CancerLung Cancer
- Interventions
- Radiation: SBRTDrug: FLT3 Ligand (CDX-301)Biological: anti-CD40 antibody (CDX-1140)
- First Posted Date
- 2020-07-29
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Albert Einstein College of Medicine
- Target Recruit Count
- 5
- Registration Number
- NCT04491084
- Locations
- 🇺🇸
Albert Einstein College of Medicine, Bronx, New York, United States
Home-Based Covid-19 Rehabilitation Program
Not Applicable
Withdrawn
- Conditions
- Covid-19
- Interventions
- Behavioral: PT-PalBehavioral: Self-guided exercises
- First Posted Date
- 2020-05-28
- Last Posted Date
- 2021-05-04
- Lead Sponsor
- Albert Einstein College of Medicine
- Registration Number
- NCT04406532
Neurostimulation for Cognitive Enhancement in Alzheimer's Disease
Not Applicable
Active, not recruiting
- Conditions
- DementiaAlzheimer Disease
- Interventions
- Device: tDCS device model Soterix mini-CT (Soterix Medical Inc., New York, NY) programed to deliver sham tDCS.Device: tDCS device model Soterix mini-CT (Soterix Medical Inc., New York, NY) programed to deliver active tDCS.
- First Posted Date
- 2020-05-27
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- Albert Einstein College of Medicine
- Target Recruit Count
- 100
- Registration Number
- NCT04404153
- Locations
- 🇺🇸
Albert Einstein College of Medicine, Bronx, New York, United States
Cervical Cancer Screening in Cameroon
Not Applicable
Completed
- Conditions
- HIV/AIDSCervical Cancer
- Interventions
- Other: HPV screening and triage testsBehavioral: HPV self-sampling
- First Posted Date
- 2020-05-26
- Last Posted Date
- 2020-05-26
- Lead Sponsor
- Albert Einstein College of Medicine
- Target Recruit Count
- 873
- Registration Number
- NCT04401670
- Locations
- 🇨🇲
Limbé Regional Hospital, Limbé, Cameroon
Study to Evaluate the Efficacy and Safety of Sirolimus in Subjects With Metastatic, Mismatch Repair Deficient Solid Tumors After Immunotherapy
Phase 2
Terminated
- Conditions
- Metastatic dMMR Solid CancerSolid TumorCancerMetastatic Solid Tumor
- Interventions
- First Posted Date
- 2020-05-19
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Albert Einstein College of Medicine
- Target Recruit Count
- 6
- Registration Number
- NCT04393454
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
© Copyright 2025. All Rights Reserved by MedPath